Home » Stocks » VTR

Ventas, Inc. (VTR)

Stock Price: $55.14 USD 1.72 (3.22%)
Updated Mar 5, 2021 4:00 PM EST - Market closed
Market Cap 20.13B
Revenue (ttm) 3.80B
Net Income (ttm) 439.15M
Shares Out 374.57M
EPS (ttm) 1.17
PE Ratio 47.13
Forward PE 263.16
Dividend $2.14
Dividend Yield 3.89%
Trading Day March 5
Last Price $55.14
Previous Close $53.42
Change ($) 1.72
Change (%) 3.22%
Day's Open 53.80
Day's Range 52.93 - 55.46
Day's Volume 2,490,569
52-Week Range 12.57 - 56.50

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 23 minutes ago

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will make a presentation regarding the Company at the virtual Citi 2021 Global Pr...

Forbes - 3 days ago

As all of the major indices have remained rather flat, Q.ai's Artificial Intelligence has assessed the data to bring you today's best short plays.

Other stocks mentioned: ALGT, CNK, PAR
Zacks Investment Research - 2 weeks ago

Decent performance of office portfolio aides Ventas (VTR) Q4 results. However, pandemic-led seniors housing woes continue to mar the senior housing operating portfolio performance.

Zacks Investment Research - 2 weeks ago

Ventas (VTR) delivered FFO and revenue surprises of 13.70% and -0.42%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 2 weeks ago

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the fourth quarter and full year ended December 31, 2020. “During 2020, Ventas's diver...

Zacks Investment Research - 2 weeks ago

Since the economic disruption and its impact have been widely varied across different property types, delving deeper into each REIT's asset fundamentals and markets is now all the more important.

Other stocks mentioned: COLD, GLPI, HST, VICI
Zacks Investment Research - 2 weeks ago

Occupancy loss amid a surge in COVID-19 cases, admission bans and high move-outs are likely to have caused occupancy declines at Ventas' (VTR) seniors housing communities, affecting Q4 residen...

Business Wire - 1 month ago

CHICAGO--(BUSINESS WIRE)---- $VTR #DEI--Ventas announced as Founding Partner - Healthcare Real Estate for the Real Estate Executive Council's (REEC) Diversity Initiative.

Business Wire - 1 month ago

CHICAGO--(BUSINESS WIRE)---- $HCSC #BoardofDirectors--Ventas, Inc. appoints Maurice Smith, President and Chief Executive Officer of Health Care Service Corporation, to its Board of Directors.

Business Wire - 1 month ago

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that it has closed a new four-year $2.75 billion unsecured credit facility (the “Credit Facility”...

Business Wire - 1 month ago

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its fourth quarter and full year 2020 earnings release prior to the opening of trading on the New York Stock Exchange on Thursday,...

Business Wire - 1 month ago

CHICAGO--(BUSINESS WIRE)---- $VTR #BloombergGEI--Ventas, Inc., (NYSE: VTR) today announced that it is one of 380 companies included in the 2021 Bloomberg Gender-Equality Index (GEI).

Business Wire - 1 month ago

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (the “Company”) announced today the tax treatment of its 2020 distributions on the Company's common stock. For income tax purposes, total tax...

Seeking Alpha - 2 months ago

I do think it's important to recognize the good that happened in 2020. There was a lot of bad – a lot of horrible, even – but there were some stories worth smiling over too.

Other stocks mentioned: ABR, DRI, EPR, EPRT, FCPT, HASI, LADR, O, VNQ
Zacks Investment Research - 2 months ago

While Ventas' (VTR) office segment has upside potential due to the high need for research related to life-saving vaccines, the challenging senior housing operating environment remains a hurdle.

The Motley Fool - 2 months ago

This resilient type of commercial real estate could be worth a look.

Other stocks mentioned: DOC
Seeking Alpha - 2 months ago

REITs have bounced since the vaccine announcement. Ventas joined in the frenzy as investors are betting on a better future.

Business Wire - 2 months ago

CHICAGO--(BUSINESS WIRE)---- $VTR #ESG--Ventas, Inc. has earned the 2020 Nareit Health Care “Leader in the Light” award for a fourth consecutive year.

Business Wire - 2 months ago

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The divi...

Zacks Investment Research - 2 months ago

Ventas (VTR) reported earnings 30 days ago. What's next for the stock?

Benzinga - 3 months ago

Health care REITs are expected to recover in 2021, driven by improving earnings growth, according to BofA Securities. The Healthcare REITs Analyst: Joshua Dennerlein upgraded the health care s...

Other stocks mentioned: OHI, WELL
Business Wire - 3 months ago

CHICAGO--(BUSINESS WIRE)---- $VTR #DEI--Ventas, Inc today took Gold at Nareit's Annual Diversity, Equity & Inclusion Recognition Awards presented during the 2020 REITworld Conference.

Business Wire - 3 months ago

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will make a presentation regarding the Company at the virtual Nareit REITworld 20...

The Motley Fool - 3 months ago

Today's vaccine news has some big implications for these businesses.

Other stocks mentioned: WELL, PEAK
Zacks Investment Research - 3 months ago

Ventas (VTR) improves its liquidity by entering into a joint venture with GIC for four developments. GIC contributes its share of costs already incurred and to be expended in future on the pro...

Seeking Alpha - 3 months ago

Ventas, Inc. (VTR) CEO Debra Cafaro on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 3 months ago

GEO vs. VTR: Which Stock Is the Better Value Option?

Other stocks mentioned: GEO
Zacks Investment Research - 3 months ago

Strong performance of triple-net leased portfolio drives Q3 net operating income growth for Ventas (VTR). However, decline in rental income impedes revenue growth.

Zacks Investment Research - 3 months ago

Ventas (VTR) delivered FFO and revenue surprises of 4.17% and -0.04%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 3 months ago

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (the “Company”) today reported results for the third quarter ended September 30, 2020. “Our solid third quarter results were driven by our st...

Business Wire - 3 months ago

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”), an S&P 500 company and one of the world's leading owners of healthcare, senior housing and research & innovation...

Zacks Investment Research - 4 months ago

The economic disruption and its impact have been widely varied across different property types and thus, delving deeper into each REIT's asset fundamentals and markets becomes all the more imp...

Other stocks mentioned: CLNY, DOC
Zacks Investment Research - 4 months ago

Ventas' (VTR) might have seen continued occupancy declines in its seniors housing assets amid the pandemic. This is expected to have hindered revenues from resident fees and services in Q3.

Seeking Alpha - 4 months ago

Ventas has had challenges, and the pandemic was the straw that broke the camel's back, forcing it to cut the dividend. I see Omega as a far better option, with mission-critical properties and ...

Other stocks mentioned: OHI
Zacks Investment Research - 4 months ago

Ventas (VTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Seeking Alpha - 4 months ago

Ventas REIT has been struggling since the pandemic. Underlying issues include a tenant base with poor rent coverage and an operating portfolio that was struggling even before COVID-19.

Business Wire - 4 months ago

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its third quarter 2020 earnings release prior to the opening of trading on the New York Stock Exchange on Friday, November 6, 2020...

Business Wire - 4 months ago

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that the Ventas Life Science and Healthcare Real Estate Fund, L.P. (the “Fund”) has acquired a tr...

CNBC - 4 months ago

Rents are rising for lab space, vacancies are plunging and research and development, and employment and new development are expanding further, thanks to strong venture capital investment. 

Other stocks mentioned: ARE, PEAK
Zacks Investment Research - 4 months ago

GEO vs. VTR: Which Stock Is the Better Value Option?

Other stocks mentioned: GEO
InvestorPlace - 4 months ago

Following news that President Donald Trump tested positive for Covid-19, it is time to sell these seven risky stocks. The post 7 Risky Stocks Still in Danger From Covid-19 appeared first on In...

Other stocks mentioned: LYV, MTN, NCLH, PLAY, SPG, UAL
Business Wire - 5 months ago

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas”) announced today the expiration and results of the previously announced offer by Ventas Realty, Limited Partnership (“Ventas Realty...

Seeking Alpha - 5 months ago

Senior housing operators have experienced significant losses this year due to COVID-19 as well as the corresponding recession.

Other stocks mentioned: CTRE, CURE, DHC, DOC, FHLC, HCA, HTA, IXJ, IYH, IYR, LTC, MPW, NHI, OHI, OLD, PEAK, PSR, RYH, SBRA, SNR, SRS, URE, VHT, VNQ
Business Wire - 5 months ago

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas”) announced today that Ventas Realty, Limited Partnership (“Ventas Realty”) and Ventas Capital Corporation (“Ventas Capital” and, to...

Seeking Alpha - 5 months ago

A lot of individual REITs sold off earlier this year and have not yet recovered.

Other stocks mentioned: BXP, EPR, HST, NNN, SPG, WELL, WPC
Business Wire - 5 months ago

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share.

Business Wire - 5 months ago

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will participate in the Bank of America Merrill Lynch 2020 Global Real Estate Vir...

Forbes - 5 months ago

For those concerned that the market is running hot and looking to hedge with bear exposure, or for short investors looking to cash in on specifically troubled companies, our artificial intelli...

Other stocks mentioned: AEO, CLF, PLUG, TEX
Forbes - 5 months ago

The stock market dealt a blow to the bears today, as it reversed course on its most difficult week since the height of the pandemic. For investors looking to make sense of a volatile and poten...

Other stocks mentioned: BREW, MTDR, OVV, PLUG
InvestorPlace - 5 months ago

The healthcare industry has historically delivered market-beating returns. And the current pandemic has created new opportunities in the sector.

Other stocks mentioned: AAPL, HCA, JNJ, NVO, SYK, TDOC

About VTR

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries – healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: co... [Read more...]

Industry
REIT-Healthcare Facilities
IPO Date
May 4, 1998
CEO
Debra Cafaro
Employees
448
Stock Exchange
NYSE
Ticker Symbol
VTR
Full Company Profile

Financial Performance

In 2020, Ventas's revenue was $3.80 billion, a decrease of -2.00% compared to the previous year's $3.87 billion. Earnings were $439.15 million, an increase of 1.42%.

Financial Statements

Analyst Forecasts

According to 22 analysts, the average rating for Ventas stock is "Hold." The 12-month stock price forecast is 49.35, which is a decrease of -10.50% from the latest price.

Price Target
$49.35
(-10.50% downside)
Analyst Consensus: Hold